Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation

Abstract

Curcumin inhibits HBV gene replication <i>via</i> down-regulation of cccDNA-bound histone acetylation and has the potential to be developed as a cccDNA-targeting antiviral agent for hepatitis B.